Segui
Giorgio Trivioli
Giorgio Trivioli
Clinical research fellow, University of Cambridge
Email verificata su cam.ac.uk
Titolo
Citata da
Citata da
Anno
Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management
G Trivioli, B Terrier, A Vaglio
Rheumatology 59 (Supplement_3), iii84-iii94, 2020
1132020
Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein)
F Maritati, R Fenoglio, E Pillebout, G Emmi, ML Urban, R Rocco, ...
Arthritis & rheumatology 70 (1), 109-114, 2018
922018
Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management
G Trivioli, A Marquez, D Martorana, M Tesi, A Kronbichler, PA Lyons, ...
Nature Reviews Rheumatology 18 (10), 559-574, 2022
562022
The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy
G Trivioli, A Vaglio
Clinical & Experimental Immunology 202 (3), 403-406, 2020
302020
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis
D Martorana, A Márquez, FD Carmona, F Bonatti, A Adorni, ML Urban, ...
Journal of Allergy and Clinical Immunology 142 (5), 1662-1665, 2018
302018
Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients
ML Urban, F Maritati, A Palmisano, P Fenaroli, F Peyronel, G Trivioli, ...
Annals of the Rheumatic Diseases 79 (3), 433-434, 2020
272020
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome
G Trivioli, S Gopaluni, ML Urban, D Gianfreda, MA Cassia, PG Vercelloni, ...
Clinical kidney journal 14 (1), 332-340, 2021
242021
Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis
M Allinovi, G Trivioli, G Lugli, M Villanti, I Gianassi, G Antognoli, ...
Nephrology Dialysis Transplantation 37 (4), 789-791, 2022
102022
Protective role for kidney TREM2high macrophages in obesity-and diabetes-induced kidney injury
A Subramanian, KA Vernon, Y Zhou, JL Marshall, M Alimova, C Arevalo, ...
Cell reports 43 (6), 2024
92024
Cluster analysis to explore clinical subphenotypes of eosinophilic granulomatosis with polyangiitis
E Rubenstein, C Maldini, A Vaglio, F Bello, JP Bremer, F Moosig, ...
The Journal of rheumatology 50 (11), 1446-1453, 2023
92023
The sound of interconnectivity; the European vasculitis society 2022 report
AC Egan, A Kronbichler, I Neumann, A Bettiol, N Carlson, MC Cid, ...
Kidney International Reports 7 (8), 1745-1757, 2022
82022
A report of 2 cases of kidney involvement in ADA2 deficiency: different disease phenotypes and the tissue response to Type I interferon
G Trivioli, E Gelain, ML Angelotti, F Ravaglia, M Allinovi, L Lodi, L Caroti, ...
American Journal of Kidney Diseases 80 (5), 677-682, 2022
42022
Assessment of biological organ age using molecular pathology in pre-transplant kidney biopsies
R Zhang, PB Trotter, J McCaffrey, R Fitzroy, G Trivioli, BJ Stewart, ...
Kidney International 106 (2), 302-316, 2024
22024
Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment—A …
M Allinovi, T Mazzierli, S Laudicina, L Pastò, E Portaccio, MP Amato, ...
Journal of Clinical Medicine 13 (6), 1598, 2024
22024
IgG4-related disease: not just a matter of IgG4
G Trivioli, M Bond, G Emmi, A Vaglio
Rheumatology 60 (Supplement_3), iii35-iii38, 2021
22021
Atrial fibrillation and kidney disease: insights on a close relationship
G Trivioli
Internal and Emergency Medicine 14 (7), 1025-1027, 2019
22019
The new generation of B cell–targeting therapies for the treatment of autoimmune kidney diseases
G Trivioli, F Peyronel, A Vaglio
Nephrology Dialysis Transplantation 39 (8), 1210-1213, 2024
12024
FC 039 RENAL OUTCOME AFTER RITUXIMAB IN ADULT-ONSET IGA VASCULITIS AND CRESCENTIC IGA NEPHROPATHY: A MULTICENTRE STUDY
G Trivioli, A Canzian, F Maritati, R Fenoglio, E Pillebout, ML Urban, ...
Nephrology Dialysis Transplantation 36 (Supplement_1), gfab117. 003, 2021
12021
Slowly progressive ANCA-associated renal vasculitis. Clinico-pathological characterisation and outcome
G Trivioli, S Gopaluni, ML Urban, D Gianfreda, M Cassia, P Vercelloni, ...
Clinical Kidney Journal, 1-9, 2020
12020
Miscellaneous organ involvement in ANCA-associated vasculitis
G Trivioli, A Vaglio
Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis, 269-292, 2019
12019
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20